Cimit News
Funding Opportunity for Neurotech Innovations: Apply for funding up to $500K
The deadline for this opportunity has passed.
Do you have a groundbreaking neurotech innovation? Cimit’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, are excited to announce our fifth funding opportunity. Submit your pre-proposal by October 4 for awards aimed at accelerating medtech solutions that address challenges associated with disorders of the nervous system.
Award Types
Optimizer Awards:
- Up to $500,000 in direct costs per year for up to 4 years.
- Ongoing mentorship from experienced executives.
- Comprehensive resources and support services.
Seedling Awards:
- 6-months of support.
- A $25,000 stipend.
- An additional $25,000 to hire subject matter experts.
- Ongoing mentorship to overcome identified gaps.
A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space. We encourage applications from women, underrepresented racial and ethnic groups, and individuals with disabilities.
The deadline for this opportunity has passed.
Do you have a groundbreaking neurotech innovation? Cimit’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, are excited to announce our fifth funding opportunity. Submit your pre-proposal by October 4 for awards aimed at accelerating medtech solutions that address challenges associated with disorders of the nervous system.
Award Types
Optimizer Awards:
- Up to $500,000 in direct costs per year for up to 4 years.
- Ongoing mentorship from experienced executives.
- Comprehensive resources and support services.
Seedling Awards:
- 6-months of support.
- A $25,000 stipend.
- An additional $25,000 to hire subject matter experts.
- Ongoing mentorship to overcome identified gaps.
A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space. We encourage applications from women, underrepresented racial and ethnic groups, and individuals with disabilities.